academyactivityanifrolumabannualbelimumabbiomarkerchildhoodclinicalcognitivecoviddiseasedysfunctioneffectsefficacyerythematosusfirsthighhighlightsimmunityimpactinsightsjournallearningmachinemanagingmaymeasuremeetingnephritispatientpatientspregnancyriskrituximabrnasesafetyslesystemictestingtherapeutictissuetreatmenttrialstypeunderstandinguseusingvalidating